Pharma Focus Asia

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercial Cooperation

Wednesday, February 20, 2019

Aucta Pharmaceuticals, Inc. ( Aucta ) announced today that it has entered into an agreement with Oakrum Pharma, LLC ( Oakrum ) to develop and produce four A prescription generic product intended to be commercialized in the United States under the Oakrum trademark. These products are expected to serve the retail market, including oral and topical medications. According to data provided by IQVIA, its potential market totaled more than $300 million in the 12 months ended December 31, 2018.

Aucta CEO Li Shoufeng said: "We chose Oakrum as the exclusive distributor of these products in the United States because the Oakrum team will bring commercial expertise to the partnership. We will continue to expand our product development portfolio and cooperation. Partnerships to help the business grow and continue to bring high quality, affordable prescription drugs to market."

Oakrum CEO Marco Polizzi said: “We are pleased to be working with Auctta for the first time in external product development. Aucta's unique product development capabilities and scientific expertise have enabled Oakrum to reach products that are difficult to copy, and these products will have Helping to achieve our goal of bringing more affordable specialty and rare disease prescription products to market. These products are part of our growing range of unique and premium low-cost pharmaceuticals."

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024